Windlas Biotech Share Price

Windlas Biotech Share Price

  • 811.30-8.46 (-1.04%)
  • Closed
  • As On: 11 Jun, 2026, 03:40 PM IST
Loading...
Open821.90
High821.90
Low804.00
Prev Close819.75
Volume47,368
VWAP(₹)810.44

Key Metrics

PE Ratio(x)25.19
EPS - TTM(₹)32.20
MCap(₹ Cr.)1,674.22
MCap Rank93
PB Ratio(x)2.91
Div Yield(%)-
Face Value(₹)5.00
52W High(₹)1,097.90
52W Low(₹)697.40
MCap/Sales1.72
Beta(1 Month)-
BV/Share(₹)281.47

Windlas Biotech share price insights

  • Employee & Interest Expense

    Company has spent less than 1% of its operating revenues towards interest expenses and 16.82% towards employee cost in the year ending Mar 31, 2026. (Source: Consolidated Financials)
  • Windlas Biotech Share Price Update

    Windlas Biotech Ltd. share price moved down by -1.04% from its previous close of Rs 819.75. Windlas Biotech Ltd. stock last traded price is 811.30

    Share PriceValue
    Today/Current/Last811.30
    Previous Day819.75

Found Insights useful?

Windlas Biotech Share Price Returns

1 Day-1.04%
1 Month1.56%
3 Months9.29%
1 Year-12.2%
3 Years192.84%
5 YearsN.A.

Windlas Biotech Share Recommendations

No Recommendations details available for this stock.
Check out other stock recos.

Share Analysis

EARNINGS
FUNDAMENTAL
RELATIVE VALUATION
RISK
PRICE MOMENTUM

Unlock Stock Score, Analyst' Ratings & Recommendations

  • Score on 10-point scale
  • Ratings by analysts
  • Stock performance
JOIN ET PRIME

Financials

  • Mar 2026Dec 2025Sep 2025Jun 2025Mar 2025
    Total Income242.85237.67226.04215.33207.64
    Total Income Growth (%)2.185.144.983.704.28
    Total Expenses221.21216.42201.44191.01185.49
    Total Expenses Growth (%)2.217.445.462.984.60
    EBIT21.6421.2524.6024.3222.15
    EBIT Growth (%)1.83-13.641.199.771.61
    Profit after Tax (PAT)15.9915.0017.8017.6616.28
    PAT Growth (%)6.59-15.720.778.494.53
    EBIT Margin (%)8.918.9410.8811.2910.67
    Net Profit Margin (%)6.586.317.878.207.84
    Basic EPS (₹)7.587.128.488.437.77
    Mar 2026Dec 2025Sep 2025Jun 2025Mar 2025
    Total Income242.90237.62226.04215.33207.65
    Total Income Growth (%)2.225.124.983.704.48
    Total Expenses221.26216.42201.44191.01185.49
    Total Expenses Growth (%)2.237.445.462.984.61
    EBIT21.6421.2024.6024.3222.15
    EBIT Growth (%)2.06-13.841.199.753.38
    Profit after Tax (PAT)16.0214.9517.8017.6716.29
    PAT Growth (%)7.10-15.990.768.476.95
    EBIT Margin (%)8.918.9210.8811.2910.67
    Net Profit Margin (%)6.596.297.878.207.84
    Basic EPS (₹)7.607.098.488.437.77
    FY 2026FY 2025FY 2024FY 2023FY 2022
    Total Revenue921.89777.90644.42523.05472.64
    Total Revenue Growth (%)18.5120.7123.2110.679.74
    Total Expenses834.92698.14567.33466.01427.07
    Total Expenses Growth (%)19.5923.0621.749.1210.31
    Profit after Tax (PAT)66.4660.4557.9442.6338.09
    PAT Growth (%)9.944.3335.9211.91140.58
    Operating Profit Margin (%)10.1511.0712.3911.2710.08
    Net Profit Margin (%)7.357.959.188.308.17
    Basic EPS (₹)31.6029.1927.9719.7018.58
    FY 2026FY 2025FY 2024FY 2023FY 2022
    Total Revenue921.89777.52644.42523.05472.64
    Total Revenue Growth (%)18.5720.6523.2110.679.74
    Total Expenses834.96698.13567.40465.99426.60
    Total Expenses Growth (%)19.6023.0421.769.2310.19
    Profit after Tax (PAT)66.4460.6558.1442.6438.56
    PAT Growth (%)9.544.3136.3510.59669.68
    Operating Profit Margin (%)10.1411.0212.3811.2710.18
    Net Profit Margin (%)7.347.989.218.318.27
    Basic EPS (₹)31.5929.0327.9519.7118.81

    All figures in Rs Cr, unless mentioned otherwise

    Insights
    • Employee & Interest Expense

      Company has spent less than 1% of its operating revenues towards interest expenses and 16.82% towards employee cost in the year ending Mar 31, 2026. (Source: Consolidated Financials)
  • AnnualFY 2026FY 2025FY 2024FY 2023FY 2022
    Total Assets907.35760.45626.21528.98491.01
    Total Assets Growth (%)19.3221.4418.387.7365.81
    Total Liabilities326.51254.68176.27126.7096.23
    Total Liabilities Growth (%)28.2144.4839.1231.66-0.79
    Total Equity580.84505.77449.94402.27394.78
    Total Equity Growth (%)14.8412.4111.851.9098.26
    Current Ratio (x)1.952.112.512.924.02
    Total Debt to Equity (x)0.050.050.000.000.02
    Contingent Liabilities0.002.0815.2914.113.25
    AnnualFY 2026FY 2025FY 2024FY 2023FY 2022
    Total Assets907.34760.45626.16529.01491.03
    Total Assets Growth (%)19.3221.4518.367.7365.89
    Total Liabilities326.51254.66175.87126.3495.90
    Total Liabilities Growth (%)28.2144.8039.2031.74-1.13
    Total Equity580.83505.79450.29402.67395.13
    Total Equity Growth (%)14.8412.3311.831.9198.57
    Current Ratio (x)1.952.112.522.924.07
    Total Debt to Equity (x)0.050.050.000.000.02
    Contingent Liabilities0.002.0815.2914.113.25

    All figures in Rs Cr, unless mentioned otherwise

  • AnnualFY 2026FY 2025FY 2024FY 2023FY 2022
    Net Cash flow from Operating Activities104.9368.19108.9660.979.13
    Net Cash used in Investing Activities-91.79-74.06-92.07-14.11-154.58
    Net Cash flow from Financing Activities-13.031.01-15.29-43.74130.09
    Net Cash Flow0.11-4.861.603.12-15.36
    Closing Cash & Cash Equivalent0.540.425.293.690.57
    Closing Cash & Cash Equivalent Growth (%)26.18-91.9843.46546.67-96.42
    Total Debt/ CFO (x)0.280.400.000.010.67
    AnnualFY 2026FY 2025FY 2024FY 2023FY 2022
    Net Cash flow from Operating Activities104.9368.23108.9160.989.00
    Net Cash used in Investing Activities-91.79-74.06-92.07-14.11-154.31
    Net Cash flow from Financing Activities-13.031.01-15.29-43.74130.09
    Net Cash Flow0.11-4.821.563.13-15.22
    Closing Cash & Cash Equivalent0.530.425.243.690.55
    Closing Cash & Cash Equivalent Growth (%)24.94-91.9742.20567.57-96.50
    Total Debt/ CFO (x)0.280.400.000.010.68

    All figures in Rs Cr, unless mentioned otherwise

    Insights
    • Increase in Cash from Investing

      Company has used Rs 91.79 cr for investing activities which is an YoY increase of 23.93%. (Source: Consolidated Financials)
  • AnnualFY 2026FY 2025FY 2024FY 2023FY 2022
    Return on Equity (%)11.4411.9512.8710.599.64
    Return on Capital Employed (%)15.6516.4617.2014.1811.83
    Return on Assets (%)7.327.949.258.057.75
    Interest Coverage Ratio (x)25.3925.5982.9389.0741.73
    Asset Turnover Ratio (x)1.081.101.091.011.18
    Price to Earnings (x)23.4736.2318.4211.0612.03
    Price to Book (x)2.684.312.371.171.16
    EV/EBITDA (x)12.9319.5611.296.365.92
    EBITDA Margin (%)13.5514.7514.5213.6812.69
    AnnualFY 2026FY 2025FY 2024FY 2023FY 2022
    Return on Equity (%)11.4311.9912.9110.599.75
    Return on Capital Employed (%)15.6416.3917.1714.1711.94
    Return on Assets (%)7.327.979.288.067.85
    Interest Coverage Ratio (x)25.3925.5083.0289.3242.06
    Asset Turnover Ratio (x)1.081.101.091.011.18
    Price to Earnings (x)23.4736.1018.3511.0611.88
    Price to Book (x)2.684.312.371.171.16
    EV/EBITDA (x)12.9419.6311.306.365.88
    EBITDA Margin (%)13.5414.7014.5113.6812.79

Found Financials useful?

Technicals

Peer Comparison

  • NAMEP/E (x)P/B (x)ROE %ROCE %ROA %Rev CAGR [3Yr]OPMNPMBasic EPSCurrent RatioTotal Debt/ Equity (x)Total Debt/ CFO (x)
    Windlas Biotech25.192.8811.4415.657.3220.5710.157.3531.601.950.050.28
    Add More stocks of your interest to compare.
    Annual Ratios (%)

    Choose from Peers

      Choose from Stocks

        • CHART
        • TABLE
        • 1D
        • 1W
        • 1M
        • 3M
        • 6M
        • 1Y
        • 5Y
        • There’s no suggested peer for this stock.

      Shareholding Pattern

      • CategoryNo. of SharesPercentage% Change QoQ
        Promoters1,30,65,35261.90 %-0.09
        Pledge00.00 %0.00
        FII1,25,8850.60 %-0.32
        DII24,91,27811.80 %0.36
        MF14,94,4217.08 %0.45
        Others54,23,71425.70 %0.06
      • CategoryMar 2026Dec 2025Sep 2025Jun 2025
        Promoters61.9061.9961.9962.34
        Pledge0.000.000.000.00
        FII0.600.931.101.44
        DII11.8011.4411.4411.21
        Mutual Funds7.086.636.396.80
        Others25.7025.6425.4725.00

      Mutual Funds Ownership

      MF Ownership as on 30 April 2026

      Corporate Actions

      • Final

        126%

        May 21, 2026

        Board Meeting

        Audited Results & Final Dividend

        May 15, 2026

        General Meeting

        Buy Back of Shares.

        Apr 17, 2026

      • Announced onMeeting on
        May 15, 2026May 21, 2026
        Audited Results & Final Dividend
        Apr 15, 2026Apr 17, 2026
        Buy Back of Shares
        Jan 28, 2026Feb 05, 2026
        Quarterly Results
        Oct 29, 2025Nov 06, 2025
        Quarterly Results
        Aug 06, 2025Aug 12, 2025
        Quarterly Results
      • Announced onEx-DateDividend%
        May 22, 2025Jul 21, 2025116%
        May 21, 2024Sep 17, 2024110%
        May 05, 2023Sep 05, 202380%
        May 12, 2022Sep 09, 202270%
        May 21, 2026-126%
      • No Data Available

      • No Data Available

      • No Data Available

      • Announced onMeeting on
        Apr 17, 2026-
        Buy Back of Shares.
        Apr 17, 2026-
        Buy Back of Shares.
        Apr 17, 2026-
        Buy Back of Shares.
        Apr 17, 2026-
        Buy Back of Shares.
        Apr 17, 2026-
        Buy Back of Shares.

      About Windlas Biotech

      Industry

      Others

      Key Indices Listed On

      BSE SmallCap, BSE Healthcare, BSE AllCap, BSE MidSmallCap

      Address

      40/1, Mohabewala Industrial Area,Dehradun, Uttarakhand/Uttaranchal - 248110

      Executive Leadership

      VD

      Vivek Dhariwal

      Chairman & Ind.Director
      HW

      Hitesh Windlass

      Managing Director
      MK

      Manoj Kumar Windlass

      Joint Managing Director
      KG

      Komal Gupta

      CEO & CFO
      Show More

      Auditors

      S S Kothari Mehta & Co. LLP
      S S Kothari Mehta & Co

      FAQs about Windlas Biotech share

      • 1. What's the Windlas Biotech share price today?
        As on 11 Jun, 2026, 03:40 PM IST Windlas Biotech share price is down by 1.04% basis the previous closing price of Rs 835.4. Windlas Biotech share price is Rs 811.30. Return Performance of Windlas Biotech Shares:
        • 1 Week: Windlas Biotech share price moved up by 0.02%
      • 2. What is the market cap of Windlas Biotech?
        Windlas Biotech share has a market capitalization of Rs 1,674.22 Cr. Within General sector, it's market cap rank is 93.
      • 3. What are the returns for Windlas Biotech share?
        Return Performance of Windlas Biotech Shares:
        • 1 Week: Windlas Biotech share price moved up by 0.02%
      • 4. What is the PE & PB ratio of Windlas Biotech?
        The PE ratio of Windlas Biotech stands at 25.46, while the PB ratio is 2.98.
      • 5. What is Windlas Biotech's 52 week high / low?
        In last 52 weeks Windlas Biotech share had a high price of Rs 1,097.90 and low price of Rs 697.40

      Top Gainers

      As on 03:59 PM | 11 Jun 2026
      Aegis Logistics
      925.90
      124.90 (15.60%)
      Zee Ent.
      111.45
      8.52 (8.28%)
      DOMS Industries
      2,255.40
      136.81 (6.46%)
      Blue Jet Healthcare
      498.45
      28.70 (6.11%)
      Wockhardt
      1,923.80
      90.80 (4.96%)

      Top Losers

      As on 03:59 PM | 11 Jun 2026
      Balkrishna Ind.
      1,974.00
      -109.20 (-5.25%)
      CCL Products
      1,133.10
      -60.31 (-5.06%)
      MRPL
      155.70
      -7.93 (-4.85%)
      Sapphire Foods
      166.91
      -8.00 (-4.57%)
      Adani Transmission
      1,466.70
      -68.90 (-4.49%)

      DATA SOURCES: TickerPlant (for live BSE/NSE quotes service) and Dion Global Solutions Ltd. (for corporate data, historical price & volume, F&O data). Sensex & BSE Quotes and Nifty & NSE Quotes are real-time and licensed from BSE and NSE respectively. All timestamps are reflected in IST (Indian Standard Time).

      DISCLAIMER: Any and all content on this website including tools/analysis is provided to you only for convenience and on an “as-is, as- available” basis without representation and warranties of any kind. The content and any output of such tools/analysis is for informational purposes only and should not be relied upon or construed as an investment advice or guarantee for any specific performance/returns advice or considered as recommendation for the purchase or sale of any security or investment. You are advised to exercise caution, discretion and independent judgment with regards to the same and seek advice from professionals and certified experts before taking any decisions.

      By using this site, you agree to the Terms of Service and Privacy Policy.